Paper - WANFANG MED ONLINE

You Position: Home > Paper

HLA-mismatched/haploidentical hematopoietic stem cell transplantation:a field in which Chinese doctors are making great contributions

( views:189, downloads:4 )

Author:: No author available

Journal Title:: CHINESE MEDICAL JOURNAL

Issue:: 10

DOI:: 10.3760/cma.j.issn.0366-6999.2010.10.001

Key Word:: allogeneic hematopoietic stem cell transplantation;haploidentical;China

Abstract： @@ Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is one of the best, or even the only,option for the cure of leukemia, especially for patients with high risk factors.1 However, it is limited by the shortage of suitable donors, because only 25%-30% patients can find a human leukocyte antigen (HLA)-identical sibling donor.

Reference

[1]袁海龙,李玲,曲建华,等.HLA单倍体相合非体外去T细胞外周血干细胞移植治疗恶性血液病36例[J].2009,(2).
[2]F, Aversa,A, Terenzi,R, Felicini,etc.Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia.[J].1998,22.
[3]Zhao XY,Chang YJ,Xu L.Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors.[J].2009,44(11).
[4]Chen XH,Zhang C,Zhang X.Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.[J].2009,15(2 Suppl.2).
[5]Liu KY,Gao ZY,Liu DH,etc.Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies.[J].2006,38(4).
[6]Tabilio A,Velardi A,Martelli MF,etc.Haploidentical stem cell transplantation in leukemia.[J].2001,15(3).
[7]Gluckman E.Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia.[J].2004,351(22).
[8]Bolanos-Meade J,Leffell MS,Jones RJ,etc.Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.[J].2008,42(8).
[9]HUANG XIAO-JUN,XU LAN-PING,LIU KAI-YAN.HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: Improved outcomes in patients in accelerated phase and blast crisis phase[J].2008,40(6).
[10]J A, Hansen,E, Petersdorf,P J, Martin,etc.Hematopoietic stem cell transplants from unrelated donors.[J].1997,157.
[11]P G, Beatty,R A, Clift,E M, Mickelson,etc.Marrow transplantation from related donors other than HLA-identical siblings.[J].1985,313.
[12]Felicini R,Reisner Y,Aloisi T,etc.Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.[J].2005,23(15).
[13]Huang X,Han W,Zhang X,etc.Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children.[J].2008,14(4).
[14]Wang JZ,Yu Wang,Zhang XH,etc.Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.[J].2009,15(5).
[15]Rizzieri DA,Koh LP,Chao NJ.Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.[J].2007,13(11).
[16]Liu J,Yan HM,Wang HX.Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement.[J].2009,50(9).
[17]H F, Seigler,F E, Ward,R C, McCoy,etc.Renal transplantation between HL-A haploidentical donor-recipient pairs: functional and morphological evaluation.[J].1976,79.
[18]Anasetti C.Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia.[J].2000,14(3).
[19]Felicini R,Aristei C,Latini P,etc.Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia.[J].1999,17(5).
[20]L, Ruggeri,M, Capanni,M, Casucci,etc.Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.[J].1999,94.
[21]Huang XJ,Liu KY,Chen H,etc.Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.[J].2007,92(3).
[22]Jun HX,Jun CY,Yu ZX.In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.[J].2004,89(12).
[23]Chen AR,Piantadosi S,Borrello I,etc.HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.[J].2008,14(6).
[24]Chao NJ,Kang Y,Aversa F.Unmanipulated or CD34 selected haplotype mismatched transplants.[J].2008,15(6).
[25]Luo XH,Chang YJ,Liu KY,etc.The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT.[J].2009,43(1).